Arquivamento - Art. 36 §1° da LPI
#11.2
08/12/2025
RPI 2849
Application data
Number
112021016400Type
Filing
Publication
PCT
EP2020054485 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 08/12/2025. We update with every new RPI gazette, published weekly.
Applicants
JANSSEN PHARMACEUTICA N.V.
BE
Inventors
C. L. (pessoa física)
BE
H. W. (pessoa física)
CN
K. K. (pessoa física)
BE
P. Z. (pessoa física)
CN
R. G. (pessoa física)
NL
IPC Classification
Priority claims
CN
PCT/CN2019/075834 · 02/22/2019
Abstract
FORMA CRISTALINA DE MONO-HIDRATO DE 1- (1-OXO-1,2-DI-HIDROISOQUINOLIN-5-IL)-5-(TRIFLUOROMETIL.)-N-(2-(TRIFLUOROMETIL)PIRIDIN-4-IL)-1H-PIRAZOL-4-CARBOXAMIDA. A presente invenção refere-se a uma forma cristalina de mono-hidrato de 1-(1-oxo-1,2-di-hidroisoquinolina-5-il)-5-(trifluorometil)-N-[2-(trifluorometil)piridina-4-il]-1H-pirazol-4-carboxamida (Composto A) e processos para a sua preparação. A forma cristalina e as suas composições são úteis no tratamento de doenças relacionadas com MALT-1.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
08/12/2025
RPI 2849
#6.23
04/08/2025
RPI 2831
#1.3
10/13/2021
RPI 2649
#1.1
08/31/2021
RPI 2643
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.